Venture Global Announces Closing of $1,000,000,000 in Senior Secured Notes from Venture Global Calcasieu Pass, LLC

Venture Global Announces Closing of $1,000,000,000 in Senior Secured Notes from Venture Global Calcasieu Pass, LLC

Arlington, Virginia (ots/PRNewswire) – Venture Global LNG, Inc. (“Venture Global”) announced today that its subsidiary Venture Global Calcasieu Pass, LLC (“VGCP”) has closed its offering of US$1,000,000,000 of 6.250% Senior …

Read more

Alphyn Biologics announces positive results from the first cohort of a Phase IIa study in the treatment of mild to moderate atopic dermatitis

Alphyn Biologics announces positive results from the first cohort of a Phase IIa study in the treatment of mild to moderate atopic dermatitis

Annapolis, Maryland (ots/PRNewswire) – The study met all primary endpoints Alphyn Biologics, a clinical trials dermatology company developing world-class multi-target therapeutics, today announced positive results from the first cohort of …

Read more